AGNG


Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

1WHO, Oct 2021

Key Information As of 05/26/23

Inception Date 05/09/16
Total Expense Ratio 0.50%
Net Assets $55.57 million
NAV $27.24
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 05/25/23

Ticker AGNG
Bloomberg Index Ticker ILNGRNT
CUSIP 37954Y772
ISIN US37954Y7720
Primary Exchange Nasdaq
Shares Outstanding 2,040,000
Number of Holdings 94
30-Day Median Bid-Ask Spread 0.35%

Distributions As of 05/26/23

30-Day SEC Yield 0.83%
Distribution Frequency Semi-Annually

ETF Prices As of 05/26/23

NAV $27.24 Daily Change -$0.01 -0.04%
Market Price $27.23 Daily Change $0.02 0.07%

Performance History

As of recent
(03/31/23)
As of recent
(03/31/23)
Fund NAV Market Price Index
1 Year -5.77% -6.05% -5.58%
3 Years 10.49% 10.40% 10.73%
5 Years 7.13% 6.99% 7.35%
Since Inception 9.37% 9.65% 9.64%
1 Year 6.54% 6.27% 6.76%
3 Years 8.36% 8.35% 8.58%
5 Years 8.48% 8.38% 8.70%
Since Inception 10.03% 10.33% 10.31%
Year-to-Date 2.40% 2.29% 2.45%
1 Month 2.44% 2.33% 2.44%
3 Months 2.40% 2.29% 2.45%
Since Inception 85.42% 88.76% 88.63%
Year-to-Date 7.62% 7.64% 7.68%
1 Month 5.10% 5.23% 5.11%
3 Months 4.79% 4.80% 4.82%
Since Inception 94.87% 98.62% 98.27%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Top Holdings As of 05/26/23

Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.56 LLY ELI LILLY & CO 2516152 425.79 3,960 1,686,128.40
3.42 ALC SW ALCON INC BJT1GR5 79.02 20,526 1,621,896.80
3.31 4519 JP CHUGAI PHARMA CO 6196408 26.71 58,674 1,567,340.63
3.21 BIIB BIOGEN INC 2455965 298.66 5,095 1,521,672.70
3.11 MDT MEDTRONIC PLC BTN1Y11 81.46 18,087 1,473,367.02
3.07 WELL WELLTOWER INC BYVYHH4 73.54 19,797 1,455,871.38
3.07 BSX BOSTON SCIENTIFIC CORP 2113434 51.06 28,475 1,453,933.50
3.06 DXCM DEXCOM INC B0796X4 115.05 12,591 1,448,594.55
3.06 NOVOB DC NOVO NORDISK A/S-B BHC8X90 163.49 8,857 1,448,035.87
3.00 AZN ASTRAZENECA PLC-SPONS ADR 2989044 72.52 19,610 1,422,117.20
3.00 EW EDWARDS LIFESCIENCES CORP 2567116 82.01 17,308 1,419,429.08
2.90 SGEN SEAGEN INC BLPK4D2 193.49 7,107 1,375,133.43
2.89 SYK STRYKER CORP 2853688 272.58 5,027 1,370,259.66
2.87 JNJ JOHNSON & JOHNSON 2475833 154.35 8,819 1,361,212.65
2.80 BMY BRISTOL-MYERS SQUIBB CO 2126335 63.82 20,789 1,326,753.98
2.73 REGN REGENERON PHARMACEUTICALS 2730190 725.05 1,786 1,294,939.30
2.66 AMGN AMGEN INC 2023607 216.93 5,809 1,260,146.37
2.66 RO SW ROCHE HOLDING AG-BR 7108918 347.02 3,631 1,260,032.85
2.62 ABBV ABBVIE INC B92SR70 137.56 9,009 1,239,278.04
2.15 4503 JP ASTELLAS PHARMA INC 6985383 16.51 61,694 1,018,536.13
1.93 ZBH ZIMMER BIOMET HO 2783815 127.65 7,181 916,654.65
1.92 GMAB DC GENMAB A/S 4595739 405.28 2,240 907,820.99
1.77 BGNE BEIGENE LTD-ADR BYYWPW6 236.90 3,536 837,678.40
1.73 STMN SW STRAUMANN HOLDING AG-REG BQ7ZV06 150.86 5,446 821,567.66
1.59 4543 JP TERUMO CORP 6885074 29.52 25,586 755,223.62
1.38 068270 KS CELLTRION INC B0C5YV1 130.70 4,990 652,156.16
1.35 PODD INSULET CORP B1XGNW4 272.63 2,352 641,225.76
1.24 UCB BB UCB SA 5596991 88.96 6,617 588,665.77
1.23 VTR VENTAS INC 2927925 42.88 13,611 583,639.68
1.16 SOON SW SONOVA HOLDING AG-REG 7156036 263.13 2,082 547,840.38
1.05 EXAS EXACT SCIENCES CORP 2719951 82.01 6,071 497,882.71
1.00 INCY INCYTE CORP 2471950 62.58 7,588 474,857.04
0.95 SN/ LN SMITH & NEPHEW PLC 0922320 15.11 29,783 450,122.29
0.91 FME GR FRESENIUS MEDICA 5129074 43.09 9,993 430,594.42
0.79 TFX TELEFLEX INC 2881407 232.35 1,612 374,548.20
0.76 COH AU COCHLEAR LTD 6211798 159.43 2,252 359,044.44
0.69 UTHR UNITED THERAPEUTICS CORP 2430412 207.32 1,582 327,980.24
0.69 3692 HK HANSOH PHARMACEU BJYKB72 1.65 198,643 327,570.73
0.67 DEMANT DC DEMANT A/S BZ01RF1 39.19 8,055 315,684.88
0.63 NBIX NEUROCRINE BIOSC 2623911 91.22 3,287 299,840.14
0.61 DVA DAVITA INC 2898087 94.28 3,061 288,591.08
0.60 AGL AGILON HEALTH INC BLR4TK4 20.26 14,075 285,159.50
0.58 AMP IM AMPLIFON SPA B14NJ71 35.33 7,830 276,619.21
0.55 NVCR NOVOCURE LTD BYSS4X4 73.56 3,568 262,462.08
0.47 OHI OMEGA HEALTHCARE 2043274 28.33 7,913 224,175.29
0.44 EXEL EXELIXIS INC 2576941 19.13 10,992 210,276.96
0.41 ACAD ACADIA PHARMACEU 2713317 24.78 7,850 194,523.00
0.38 BPMC BLUEPRINT MEDICINES CORP BWY52P3 57.75 3,103 179,198.25
0.37 DNLI DENALI THERAPEUTICS INC BD2B4V0 29.96 5,897 176,674.12
0.36 ENSG ENSIGN GROUP INC/THE B1YWPP8 88.57 1,939 171,737.23
0.35 AGIO AGIOS PHARMACEUTICALS INC BCBVTX1 25.82 6,503 167,907.46
0.35 ALEC ALECTOR INC BJ4LDC4 7.59 22,116 167,860.44
0.35 KOREAN WON 0.00 219,868,938 166,007.73
0.34 GKOS GLAUKOS CORP BYMWL19 54.85 2,967 162,739.95
0.34 GN DC GN STORE NORD A/S 4501093 25.80 6,278 161,998.06
0.34 MMSI MERIT MEDICAL SYSTEMS INC 2580555 81.44 1,959 159,540.96
0.34 MNKD MANNKIND CORP BF081J4 4.54 34,958 158,709.32
0.33 145720 KS DENTIUM CO LTD BF07GJ6 120.58 1,306 157,475.33
0.33 RYM NZ RYMAN HEALTHCARE LTD 6161525 3.64 42,962 156,511.44
0.32 HALO HALOZYME THERAPEUTICS INC 2975098 33.20 4,591 152,421.20
0.32 NHC NATIONAL HEALTHCARE CORP 2139731 60.01 2,528 151,705.28
0.32 KORI FP KORIAN B1HKRM0 8.03 18,665 149,963.41
0.32 CSH-U CN CHARTWELL RETIRE B8S8C94 6.57 22,771 149,698.09
0.32 LIVN LIVANOVA PLC BYMT0J1 44.02 3,396 149,491.92
0.31 NHI NATL HEALTH INVESTORS INC 2626125 51.61 2,878 148,533.58
0.31 SIA CN SIENNA SENIOR LIVING INC BWTYXH4 8.25 17,879 147,456.21
0.31 ITGR INTEGER HOLDINGS CORP BD06LM7 80.37 1,817 146,032.29
0.31 SGHT SIGHT SCIENCES INC BN2T5Q6 9.25 15,726 145,465.50
0.30 ANGO ANGIODYNAMICS INC B00CR04 9.29 15,476 143,772.04
0.30 8086 JP NIPRO CORP 6641599 7.17 19,710 141,271.72
0.30 EKTAB SS ELEKTA AB-B SHS B0M42T2 7.93 17,678 140,154.69
0.29 AMED AMEDISYS INC 2024332 77.31 1,800 139,158.00
0.29 EMBC EMBECTA CORP BMXWYR1 26.90 5,090 136,921.00
0.29 TBPH THERAVANCE BIOPHARMA INC BMNDK09 11.06 12,226 135,219.56
0.28 DCPH DECIPHERA PHARMA BZ1LFB2 13.79 9,751 134,466.29
0.28 ATEC ALPHATEC HOLDINGS INC BD60BG7 14.32 9,228 132,144.96
0.28 CANO CANO HEALTH INC BN0WWW2 1.26 103,266 130,115.16
0.27 SBRA SABRA HEALTH CAR B5NLBP6 10.51 12,375 130,061.25
0.27 LTC LTC PROPERTIES INC 2498788 31.22 4,164 130,000.08
0.27 6600 HK SCICLONE PHARMAC BMX5ZW2 1.33 96,800 128,492.57
0.27 AED BB AEDIFICA B1G5XP1 70.12 1,812 127,059.20
0.27 NUVA NUVASIVE INC B00GJC2 37.12 3,404 126,356.48
0.26 2186 HK LUYE PHARMA GROUP LTD BNQ4GF3 0.44 283,424 124,803.00
0.26 FGEN FIBROGEN INC BSDRYR8 16.70 7,401 123,596.70
0.26 AMRN AMARIN CORP PLC -ADR 2301938 1.19 103,370 123,010.30
0.26 9229 JP SUNWELS CO LTD BNTYNB5 20.93 5,819 121,809.88
0.25 BKD BROOKDALE SR B0PZN33 3.43 35,032 120,159.76
0.24 PHM SM PHARMA MAR SA BMW2GT8 36.89 3,136 115,690.57
0.24 1302 HK LIFETECH SCIENTIFIC CORP BV9FKS0 0.31 357,792 111,426.83
0.24 SILK SILK ROAD MEDICAL INC BGHVXJ7 30.65 3,627 111,167.55
0.23 1858 HK BEIJING CHUNLI-H BVVPXP6 2.01 55,116 110,585.85
0.23 853 HK MICROPORT SCIENTIFIC CORP B676TW7 1.83 59,702 109,119.21
0.22 1789 HK AK MEDICAL HOLDINGS LTD BFD6SZ0 0.94 111,189 105,017.79
0.21 2500 HK VENUS MEDTECH -H BL6V047 1.03 97,440 100,364.50
0.06 CANADIAN DOLLAR 0.73 36,864 27,020.22
0.01 EURO 1.07 4,022 4,305.83
0.00 BRITISH STERLING POUND 1.17 0 0.07
0.00 RADIUS HEALTH INC - CVR 2KFF9T0 0.00 19,104 0.00
0.00 JAPANESE YEN 0.01 -2 -0.01
0.00 SWISS FRANC 1.00 0 -0.02
0.00 AUSTRALIAN DOLLAR 0.62 0 -0.08
-0.20 CASH 1.00 -93,429 -93,428.66
Holdings are subject to change. "Cash" denotes U.S. dollars.

Sector Breakdown As of 04/30/23

Sector Weight (%)
Health Care 93.9
Real Estate 6.1

Source: AltaVista Research, LLC

Country Breakdown As of 04/30/23

Country Weight (%)
United States 58.1
Switzerland 8.6
Japan 7.1
Denmark 6.0
Britain 4.7
China 4.6
Ireland 3.6
Belgium 1.6
South Korea 1.5
Germany 1.0
Australia 0.7
Other/Cash 2.5

Source: AltaVista Research, LLC

ETF Characteristics As of 05/26/23

Return on Equity 12.00%
Weighted Avg. Market Cap 60,531 M
2022 2023
Price-to-earnings 25.90 27.06
Price-to-book value 3.37 3.15

Source: AltaVista Research, LLC

ETF Risk Stats As of 04/30/23

Versus Beta
S&P 500 0.67
NASDAQ-100 0.48
MSCI EAFE 0.69
MSCI Emg. Mkts 0.46
Standard Deviation 15.90%

Source: AltaVista Research, LLC

ETF Research

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

Back to Top